The Alliance for Regenerative Medicine held a private reception for cell and gene therapy industry executives during Advanced Therapies Week on Wednesday, January 17, 2024 . Attendees enjoyed extensive networking opportunities with the sector’s top decision makers including executives from leading companies!
ARM’s hybrid 2024 Cell & Gene State of the Industry Briefing attracted over 800+ key stakeholders in the field. This event included ARM’s annual yearly update on the sector’s progress followed by two noteworthy sessions featuring top CEOs and executives highlighting future inflection points for cell and gene therapies in the coming year.
On November 1st, ARM convened key stakeholders from the Cell & Gene Therapy industry and held a Scientific Exchange meeting with FDA to improve the time and resource efficiency of development and regulatory review by leveraging elements that can serve as building blocks across programs.
The Alliance for Regenerative Medicine held a 1-day workshop on Tissue Engineering and Therapeutics on September 6, 2023, in the Rockville, MD area. This workshop highlighted scientific advances, CMC and regulatory insights, and funding perspectives.
The event will focus on the revision of the EU pharmaceuticals legislation and the EU Joint Clinical Assessment of ATMPs and how these policy initiatives will affect Europe’s competitiveness in the cell and gene therapy sector.
ARM and USP held a 1.5 day workshop on AAV Analytical Characterization on March 8-9, 2023, in the Washington DC area. This workshop covered various topics on AAV quality, including full / empty capsid characterization, potency assay, and titer measurements.
12601 Twinbrook Pkwy
Rockville, MD 20852
ARM will be hosting an information session on the upcoming 2023 GROW Internship Program cycle for member companies on Wednesday, November 9th at 1pm EST.